| Literature DB >> 29799455 |
Jian Sun1,2, Yu-Tao Zhang3, Yu-Min Niu4, Hai-Jiao Li5, Yu Yin6, Yi-Zhe Zhang7, Pei-Bin Ma8, Jing Zhou9, Jun-Jia Lu10, Hong-Shun Zhang11, Cheng-Ye Sun12.
Abstract
Amatoxin poisoning induces delayed-onset acute liver failure, which are responsible for more than 90% of deaths in mushroom poisoning. It has been postulated from animal and human studies that biliary drainage interrupting enterohepatic amatoxin circulation may affect amatoxin poisoning. Dogs were randomly divided into four groups of six animals each. In 20 mg/kg and 60 mg/kg with biliary drainage groups, after accepting bile drainage operation, beagles were fed Amanita exitialis powder (20 or 60 mg/kg) in starch capsules. In control and bile drainage groups, the beagle dogs were fed with empty capsules. They were assessed for toxicity signs, biochemical and pathological changes, and peptide toxins in plasma, urine and bile. The data were directly compared with those from our published studies on Amanita exitialis-exposed beagles without biliary drainage. Amatoxins were rapidly absorbed and eliminated from plasma after Amanita exitialis ingestion. Amatoxins in 0⁻1-day urine accounted for more than 90% of the total urine excretion, and amatoxins in bile accounted for less than 20% of the total urine and bile excretion. The dogs with biliary drainage showed less severe toxicity signs and biochemical and pathological changes and much lower internal exposure than dogs without biliary drainage. Biliary drainage caused a more than 70% reduction in intestinal amatoxin absorption and could reduce amatoxin absorption from the gastrointestinal tract.Entities:
Keywords: Amanita exitialis; amatoxins; beagles; bile drainage; urine
Mesh:
Substances:
Year: 2018 PMID: 29799455 PMCID: PMC6024615 DOI: 10.3390/toxins10060215
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Peptide toxin concentrations in Amanita exitialis (mg/kg dry weight).
| Peptide Toxin | Toxin Concentration (mg/kg) | Mean | Standard Deviation (SD) | ||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | (mg/kg) | (mg/kg) | |
| α-amanitin | 1934.6 | 1996.8 | 1891.4 | 2060 | 1947.8 | 1966.1 | 64.6 |
| β-amanitin | 992.6 | 995.2 | 857.4 | 902.9 | 827.2 | 915.1 | 76.9 |
| γ-amanitin | 8.6 | 8.5 | 8.6 | 8.2 | 8.7 | 8.5 | 0.2 |
| phallacidin | 618.6 | 636.1 | 575.8 | 672.7 | 508.2 | 602.3 | 63.1 |
| Total | 3554.4 | 3636.6 | 3333.2 | 3643.8 | 3291.9 | 3492 | 168.2 |
Signs of toxicity and death in beagles following ingestion of Amanita exitialis.
| Toxic Signs | Number of Dogs (%) | Time from Ingestion to Onset (h) | ||
|---|---|---|---|---|
| 20 mg/kg with Biliary Drainage Group | 60 mg/kg with Biliary Drainage Group | 20 mg/kg with Billary Drainage Group | 60 mg/kg with Billary Drainage Group | |
| Loss of appetite | 0 (0%) | 3 (50%) | - | 12–48 |
| Vomiting | 0 (0%) | 3 (50%) | - | 12–24 |
| Diarrhea | 0 (0%) | 3 (50%) | - | 12–24 |
| Weakness | 0 (0%) | 0 (0%) | - | - |
| Hematemesis | 0 (0%) | 0 (0%) | - | - |
| Hematochezia | 0 (0%) | 0 (0%) | - | - |
| Death | 0 (0%) | 0 (0%) | - | - |
Figure 1Blood chemistry profiles of beagles in different experimental groups: (a) ALT level; (b) AST level; (c) TBIL level; (d) DBIL level; (e) ALP level; (f) PT level; (g) APTT level; and (h) INR level.
Figure 2Dynamic changes of peptide toxins in the blood of beagles in different experimental group: (a) α-amanitin levels; (b) β-amanitin levels; and (c) phallacidin levels.
Toxicokinetic parameters for peptide toxins of beagles in different experimental groups
| Parameter | α-Amanitin | β-Amanitin | Phallacidin | |||
|---|---|---|---|---|---|---|
| 20 mg/kg with Biliary Drainage Group | 60 mg/kg with Biliary Drainage Group | 20 mg/kg with Biliary Drainage Group | 60 mg/kg with Biliary Drainage Group | 20 mg/kg with Biliary Drainage Group | 60 mg/kg with Biliary Drainage Group | |
| T1/2 (h) | 1.08 ± 0.76 | 1.2 ± 0.58 | 1.29 ± 1.07 | 1.54 ± 0.71 | - | 0.62 ± 0.32 b,* |
| AUC (0–∞) (µg/L × h) | 5.36 ± 3.17 | 31.99 ± 9.65 a,* | 3.24 ± 1.49 | 15.75 ± 4.27 a,b | - | 2.08 ± 2.06 b,* |
| Dose normalized AUC (0–∞) | 138.9 ± 82.1 | 238.2 ± 83.9 | 179 ± 82.4 | 222.3 ± 79.2 | - | 60.5 ± 60.2 b,* |
| Cmax (µg/L) | 1.73 ± 0.58 | 12.25 ± 3.54 a,* | 0.85 ± 0.33 | 5.18 ± 1.32 a,b | - | 0.85 ± 0.37 b,* |
| Dose normalized Cmax | 44 ± 15.1 | 86.1 ± 30.8 | 57 ± 18.3 | 96 ± 24.4 | - | 24.8 ± 10.8 b,* |
| Tmax (h) | 1.38 ± 0.48 | 1.13 ± 0.25 | 1.63 ± 0.48 | 1.25 ± 0.29 | - | 1.38 ± 0.25 |
| CL/F (L/h/kg) | 0.85 ± 0.43 | 0.36 ± 0.11 | 0.64 ± 0.42 | 0.33 ± 0.09 | - | 1.1 ± 0.86 b,* |
| Vz/F (L/kg) | 1.07 ± 0.31 | 0.68 ± 0.48 | 0.78 ± 0.63 | 1.38 ± 0.59 | - | 1.77 ± 0.57 b,* |
| MRT (0–∞) (h) | 3.55 ± 0.8 | 2.87 ± 0.43 | 3.83 ± 1.02 | 3.89 ± 0.46 | - | 1.95 ± 0.73 b,* |
We could not calculate the toxicokinetic parameters because phallacidin was not detected in serum in the 20 mg/kg with biliary drainage group. a indicates p ≤ 0.05 when compared to the same toxin in the 20 mg/kg with biliary drainage group. b indicates p ≤ 0.05 when compared to α-amanitin in the same experimental group. * indicates p ≤ 0.05 when compared to β-amanitin in the same experimental group.
The daily amounts of peptide toxins excreted in urine in beagles with biliary drainage (mg).
| Time after Ingestion | α-Amanitin | β-Amanitin | Phallacidin | |||
|---|---|---|---|---|---|---|
| 20 mg/kg with Biliary Drainage Group | 60 mg/kg with Biliary Drainage Group | 20 mg/kg with Biliary Drainage Group | 60 mg/kg with Biliary Drainage Group | 20 mg/kg with Biliary Drainage Group | 60 mg/kg with Biliary Drainage Group | |
| 0–1 days | 0.0147 | 0.0213 | 0.0050 | 0.0065 | 0.0012 | 0.0017 |
| 1–2 days | 0.0004 | 0.0007 | 0.0005 | 0.0003 | 0.0001 | 0.0005 |
| 2–3 days | 0(0%) | 0.0001 | 0(0%) | 0(0%) | 0(0%) | 0.0002 |
| 3–4 days | 0(0%) | 0(0%) | 0(0%) | 0(0%) | 0(0%) | 0(0%) |
| Total | 0.0151 | 0.0222 | 0.0055 | 0.0068 | 0.0014 | 0.0025 |
The data in parentheses are the percentages of peptide toxins excreted daily in bile.
The daily amounts of peptide toxins excreted in bile in beagles with biliary drainage (mg).
| Time after Ingestion | α-Amanitin | β-Amanitin | Phallacidin | |||
|---|---|---|---|---|---|---|
| 20 mg/kg with Biliary Drainage Group | 60 mg/kg with Biliary Drainage Group | 20 mg/kg with Biliary Drainage Group | 60 mg/kg with Biliary Drainage Group | 20 mg/kg with Biliary Drainage Group | 60 mg/kg with Biliary Drainage Group | |
| 0–1 days | 0.00007 | 0.00061 | 0.00014 | 0.00122 | 0.00005 | 0.00020 |
| 1–2 days | 0(0%) | 0(0%) | 0(0%) | 0(0%) | 0(0%) | 0.00004 |
| 2–3 days | 0(0%) | 0(0%) | 0(0%) | 0(0%) | 0(0%) | 0(0%) |
| 3–4 days | 0(0%) | 0(0%) | 0(0%) | 0(0%) | 0(0%) | 0(0%) |
| Accumulated amounts | 0.00007 | 0.00061 | 0.00014 | 0.00122 | 0.00005 | 0.00024 |
The data in parentheses are the percentages of peptide toxins excreted daily in bile.
The ratio of peptide toxins in bile to excretion in urine and bile.
| Peptide Toxin | 20 mg/kg with Biliary Drainage Group (%) | 60 mg/kg with Biliary Drainage Group (%) |
|---|---|---|
| α-Amanitin | 1.3 ± 2.4 | 3.1 ± 2.5 |
| β-Amanitin | 5.7 ± 8.5 | 15.4 ± 10.6 |
| Phallacidin | 4.8 ± 5.7 | 9.4 ± 6.4 |